Status:
RECRUITING
A Phase I Study to Evaluate LIFE-001
Lead Sponsor:
LifeMine Therapeutics
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The goal of this clinical trial is to learn if LIFE-001 is safe and tolerable for healthy adult volunteers.
Detailed Description
Participants will attend the site where dosing will be done subcutaneously via direct staff administration and they can only participate in one of the following cohorts: Single Ascending Dose (SAD) C...
Eligibility Criteria
Inclusion
- Female or male between the ages of 18 and 65 years, inclusive
- Medically healthy (without significant medical issues, e.g. high blood pressure)
- Must provide written informed consent
Exclusion
- Ongoing or history of any psychiatric, medical or surgical condition that might jeopardize the participant's safety or interfere with the absorption, distribution or excretion of the study drug
- Any abnormal ECG findings, laboratory value or physical examination findings
- Positive ethanol, drug screen or cotinine test
- Use of systemic prescription medications or over-the-counter (OTC) medication, including multivitamins, and dietary and herbal supplement within 7 days
- Use of any experimental or investigational device within 30 days
- Donation or loss of 500 mL or more of blood within 30 weeks and/or donation of plasma within 30 days
Key Trial Info
Start Date :
April 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06904807
Start Date
April 7 2025
End Date
March 31 2026
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Veritus Research Pty Ltd
Bayswater, Victoria, Australia, 3163